Efficacy of Serotonin and Dopamine Activity Modulators in the Treatment of Negative Symptoms in Schizophrenia: A Rapid Review
Schizophrenia is among the fifteen most disabling diseases worldwide. Negative symptoms (NS) are highly prevalent in schizophrenia, negatively affect the functional outcome of the disorder, and their treatment is difficult and rarely specifically investigated. Serotonin-dopamine activity modulators...
Main Authors: | Claudio Brasso, Gianluca Colli, Rodolfo Sgro, Silvio Bellino, Paola Bozzatello, Cristiana Montemagni, Vincenzo Villari, Paola Rocca |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/3/921 |
Similar Items
-
Risperidone Decreases Expression of Serotonin Receptor-2A (5-HT2A) and Serotonin Transporter (SERT) but Not Dopamine Receptors and Dopamine Transporter (DAT) in PBMCs from Patients with Schizophrenia
by: Samantha Alvarez-Herrera, et al.
Published: (2024-01-01) -
Alterations in Serotonin Neurotransmission in Hyperdopaminergic Rats Lacking the Dopamine Transporter
by: Dmitrii S. Traktirov, et al.
Published: (2023-10-01) -
Assessing NH300094, a novel dopamine and serotonin receptor modulator with cognitive enhancement property for treating schizophrenia
by: Zijin Feng, et al.
Published: (2024-01-01) -
Role of Serotonin in Schizophrenia
by: Ebru Oztepe Yavasci, et al.
Published: (2012-06-01) -
Conceptual disorganization as a mediating variable between visual learning and metacognition in schizophrenia
by: Cristiana Montemagni, et al.
Published: (2023-12-01)